Nuo Therapeutics Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Gaithersburg MD United States (1987)
Status: No NME R&D (1987)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

Key: Nuo Therapeutics (0) Acquired (1)

ald-101 (1 trial)

Drugs in Phase 2 Trials (2)

Key: Nuo Therapeutics (0) Acquired (2)

ald-301 (1 trial)

ald-401 (1 trial)

Drugs in Phase 1 Trials (3)

Key: Nuo Therapeutics (0) Acquired (3)

ald-601 (1 trial)

aldhbr umbilical cord blood cells (1 trial)

stem cells (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 6
  • # of Trial APIs: 6